Exact Mass: 313.0313

Exact Mass Matches: 313.0313

Found 13 metabolites which its exact mass value is equals to given mass value 313.0313, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Maybridge3_004791

Maybridge3_004791

C13H16BrNO3 (313.0313)


   

6-(BROMOMETHYL)-4-(3-METHOXYPROPYL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

6-(BROMOMETHYL)-4-(3-METHOXYPROPYL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

C13H16BrNO3 (313.0313)


   

2-BROMO-4-METHOXY-6-NITROBENZENOL

2-BROMO-4-METHOXY-6-NITROBENZENOL

C13H16BrNO3 (313.0313)


   

[2-(3-BROMO-PHENYL)-2-OXO-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

[2-(3-BROMO-PHENYL)-2-OXO-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

C13H16BrNO3 (313.0313)


   

tert-Butyl 6-bromo-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate

tert-Butyl 6-bromo-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate

C13H16BrNO3 (313.0313)


   

tert-Butyl N-[2-(4-bromophenyl)-2-oxoethyl]carbamate

tert-Butyl N-[2-(4-bromophenyl)-2-oxoethyl]carbamate

C13H16BrNO3 (313.0313)


   

4-[(4-Bromo-2-ethoxyphenyl)carbonyl]morpholine

4-[(4-Bromo-2-ethoxyphenyl)carbonyl]morpholine

C13H16BrNO3 (313.0313)


   

ethyl 5-bromo-2-morpholin-4-ylbenzoate

ethyl 5-bromo-2-morpholin-4-ylbenzoate

C13H16BrNO3 (313.0313)


   

ethyl 3-bromo-4-morpholin-4-ylbenzoate

ethyl 3-bromo-4-morpholin-4-ylbenzoate

C13H16BrNO3 (313.0313)


   

N-Boc-4-(2-Bromo-acetyl)-aniline

N-Boc-4-(2-Bromo-acetyl)-aniline

C13H16BrNO3 (313.0313)


   

N-Boc-7-Bromo-3,4-dihydro-2H-benzo[1,4]oxazine

N-Boc-7-Bromo-3,4-dihydro-2H-benzo[1,4]oxazine

C13H16BrNO3 (313.0313)


   

7-Amino-3-(1,2,3-triazol-4-ylthio)methyl cephalosporanic acid

7-Amino-3-(1,2,3-triazol-4-ylthio)methyl cephalosporanic acid

C10H11N5O3S2 (313.0303)


   

KRA-533

KRA-533

C13H16BrNO3 (313.0313)


KRA-533 is a potent KRAS agonist. KRA-533 binds to the GTP/GDP binding pocket in the KRAS protein to prevent GTP cleavage, resulting in the accumulation of constitutively active GTP-bound KRAS that triggers both apoptotic and autophagic cell death pathways in cancer cells.